Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7695

1.

Correction.

[No authors listed]

Value Health. 2019 Mar;22(3):383. doi: 10.1016/j.jval.2018.11.004. Epub 2018 Nov 27. No abstract available.

PMID:
30832980
2.

Correction.

[No authors listed]

Value Health. 2019 Mar;22(3):383. doi: 10.1016/j.jval.2018.11.003. Epub 2018 Nov 27. No abstract available.

PMID:
30832979
3.

Correction.

[No authors listed]

Value Health. 2019 Mar;22(3):383. doi: 10.1016/j.jval.2018.11.002. Epub 2018 Nov 27. No abstract available.

PMID:
30832978
4.

Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018.

Watts RD, Li IW.

Value Health. 2019 Mar;22(3):377-382. doi: 10.1016/j.jval.2018.10.006. Epub 2018 Dec 14. Review.

PMID:
30832977
5.

Valuation of Health States Considered to Be Worse Than Death-An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies.

Gandhi M, Rand K, Luo N.

Value Health. 2019 Mar;22(3):370-376. doi: 10.1016/j.jval.2018.10.002. Epub 2018 Nov 12.

PMID:
30832976
6.

Evaluating Canadians' Values for Drug Coverage Decision Making.

Rizzardo S, Bansback N, Dragojlovic N, Douglas C, Li KH, Mitton C, Marra C, Blanis L, Lynd LD.

Value Health. 2019 Mar;22(3):362-369. doi: 10.1016/j.jval.2018.08.008. Epub 2018 Nov 27.

PMID:
30832975
7.

Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups.

Feng Y, Devlin N, Bateman A, Zamora B, Parkin D.

Value Health. 2019 Mar;22(3):355-361. doi: 10.1016/j.jval.2018.08.012. Epub 2018 Nov 1.

PMID:
30832974
8.

Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE.

Oluboyede Y, Tomos Robinson.

Value Health. 2019 Mar;22(3):348-354. doi: 10.1016/j.jval.2018.10.001.

PMID:
30832973
9.

Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials.

Arbuckle R, Staunton H, Sully K, Tomkins S, Khindri S, Svedsater H, Nelsen L.

Value Health. 2019 Mar;22(3):340-347. doi: 10.1016/j.jval.2018.09.2845. Epub 2018 Dec 6.

PMID:
30832972
10.

Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports.

Snider JT, Sussell J, Tebeka MG, Gonzalez A, Cohen JT, Neumann P.

Value Health. 2019 Mar;22(3):332-339. doi: 10.1016/j.jval.2018.10.005. Epub 2018 Dec 14.

PMID:
30832971
11.

Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non-Small Cell Lung Cancer Using Real-World Data.

Holleman MS, Uyl-de Groot CA, Goodall S, van der Linden N.

Value Health. 2019 Mar;22(3):322-331. doi: 10.1016/j.jval.2018.08.007. Epub 2018 Oct 26.

PMID:
30832970
12.

Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine.

Hoogendoorn M, Corro Ramos I, Baldwin M, Gonzalez-Rojas Guix N, Rutten-van Mölken MPMH.

Value Health. 2019 Mar;22(3):313-321. doi: 10.1016/j.jval.2018.10.008. Epub 2018 Dec 20.

PMID:
30832969
13.

Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data.

Fawsitt CG, Thom HHZ, Hunt LP, Nemes S, Blom AW, Welton NJ, Hollingworth W, López-López JA, Beswick AD, Burston A, Rolfson O, Garellick G, Marques EMR.

Value Health. 2019 Mar;22(3):303-312. doi: 10.1016/j.jval.2018.08.013. Epub 2018 Nov 2.

PMID:
30832968
14.

Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.

Parkinson B, Gumbie M, Cutler H, Gauld N, Mumford V, Haywood P.

Value Health. 2019 Mar;22(3):293-302. doi: 10.1016/j.jval.2018.09.2840. Epub 2018 Dec 24.

PMID:
30832967
15.

Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.

Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC.

Value Health. 2019 Mar;22(3):284-292. doi: 10.1016/j.jval.2018.10.004. Epub 2018 Nov 27.

PMID:
30832966
16.

Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study.

Bullement A, Latimer NR, Bell Gorrod H.

Value Health. 2019 Mar;22(3):276-283. doi: 10.1016/j.jval.2018.10.007. Epub 2018 Dec 13.

PMID:
30832965
17.

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.

Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, Cruz L, Karnon J, Lloyd A, Paisley S, Pickard AS.

Value Health. 2019 Mar;22(3):267-275. doi: 10.1016/j.jval.2019.01.004.

PMID:
30832964
18.

Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled "Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis".

Vignon Zomahoun HT, de Bruin M, Guillaumie L, Moisan J, Grégoire JP, Guénette L, Pérez N, Vézina-Im LA.

Value Health. 2019 Feb;22(2):264-266. doi: 10.1016/j.jval.2018.07.003. Epub 2018 Aug 9. No abstract available.

PMID:
30711074
19.

The Retraction of a Trial Included in a Meta-Analysis of Interventions to Enhance Oral Medication Adherence.

Gray R, Al-Ghareeb A, Davis J, McKenna L, Hillel SA.

Value Health. 2019 Feb;22(2):263-264. doi: 10.1016/j.jval.2018.07.005. Epub 2018 Aug 20. No abstract available.

PMID:
30711073
20.

Economic Evaluation of Stem Cell Therapies in Neurological Diseases: A Systematic Review.

Nagpal A, Milte R, Kim SW, Hillier S, Hamilton-Bruce MA, Ratcliffe J, Koblar SA.

Value Health. 2019 Feb;22(2):254-262. doi: 10.1016/j.jval.2018.07.878. Epub 2018 Aug 31. Review.

PMID:
30711072

Supplemental Content

Loading ...
Support Center